CYCCP - Cyclacel Pharmaceuticals Inc. (CYCC) CEO Spiro Rombotis on Q4 2021 Results - Earnings Call Transcript
Cyclacel Pharmaceuticals, Inc. (CYCC) Q4 2021 Results Conference Call March 28, 2022 04:30 PM ET Company Participants Spiro Rombotis - President and CEO Paul McBarron - EVP, Finance and COO Dr. Mark Kirschbaum - SVP and Chief Medical Officer Conference Call Participants Kevin DeGeeter - Oppenheimer Ahu Demir - Ladenburg Jonathan Aschoff - ROTH Capital Kumar Raja - Brookline Presentation Operator Good afternoon, and welcome to the Cyclacel Pharmaceuticals Fourth Quarter and Full Year 2021 Results Conference Call and Webcast. [Operator Instructions] Please note, today’s call is being recorded. I would now like to turn the conference call over to the Company. Unidentified Company Representative Good afternoon, everyone, and thank you for joining today’s conference call to discuss Cyclacel’s financial results and business highlights for the fourth quarter and full year 2021. Before turning the call over to management, I would like to remind everyone that during this conference call,
For further details see:
Cyclacel Pharmaceuticals, Inc. (CYCC) CEO Spiro Rombotis on Q4 2021 Results - Earnings Call Transcript